Henry Schein Inc

Análisis de la acción Henry Schein Inc (HSIC)

$89.520

-0.752 (-0.84%)Al cierre

Loading chart…
High
91.090
Open
90.540
VWAP
90.03
Vol
795.97K
Mkt Cap
8.21B
Low
89.470
Amount
71.66M
EV/EBITDA, TTM
11.85

Henry Schein, Inc. is a solutions company for health care professionals. Its segments consist of Global Distribution and Value-Added Services, Global Specialty Products and Global Technology. Global Distribution and Value-Added Services include distribution to the global dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting and other practice services. This segment also markets and sells, under its own corporate brand, a portfolio of consumable merchandise. Global Specialty Products includes manufacturing, marketing and sales of dental implant and biomaterial products; endodontic, orthodontic and orthopedic products and other health care-related products and services. Global Technology includes development and distribution of practice management software, e-services, and other products.

www.henryschein.com

AI analysis of Henry Schein Inc (HSIC)

buy

Henry Schein Inc is a good buy right now due to its solid financial performance and positive market sentiment. The current price is $89.52, and the company reported a strong Q2 with a net income of $94 million and an EPS of $0.82, up from $0.70 last year. Additionally, the forward P/E ratio of 17.51 indicates attractive valuation relative to future earnings. However, the main risk is the debt to equity ratio, which is currently at 90.70%, indicating a high level of debt that could impact financial stability if not managed well.

Analyst Ratings (16)

-14.23% downside
Buy
9 Buy
7 Hold
0 Sell
Current: 89.52
Mínimo
58.00
Promedio
76.78
Máximo
90.00

BTIG

2026-08-19

Precio objetivo

$110

Buy

Barclays

2026-08-06

Precio objetivo

$100

Overweight

Mizuho

2026-08-05

Precio objetivo

$86

Neutral

UBS

2026-08-05

Precio objetivo

$94

Neutral

Barrington

2026-08-05

Precio objetivo

$104

Outperform
See All Ratings

Métricas de valoración

The current forward P/E ratio for Henry Schein Inc (HSIC) is 17.51, compared to its 5-year average forward P/E of 15.23.

Forward P/E

Overvalued
5Y Average P/E
15.23
Current P/E
17.51
Sobrevalorada
16.80
Infravalorada
13.66

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
11.75
Current EV/EBITDA
11.85
Sobrevalorada
12.49
Infravalorada
11.01

Forward P/S

Fair
5Y Average P/S
0.74
Current P/S
0.70
Sobrevalorada
0.84
Infravalorada
0.64

Alphio AI Price Scenarios for HSIC

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%HSIC

$82.44

Precio del escenario

B

Base

Base · 50%HSIC

$70.37

Precio del escenario

B

Bear

Bear · 25%HSIC

$57.21

Precio del escenario

Whales holding HSIC

L

Lakewood Capital Management, LP

+ HoldingHSIC

+12.37%

3M Return

B

Burgundy Asset Management Ltd.

+ HoldingHSIC

+11.17%

3M Return

S

Snyder Capital Management, L.P.

+ HoldingHSIC

+5.37%

3M Return

F

Fiduciary Management, Inc.

+ HoldingHSIC

+5.10%

3M Return

T

Thompson, Siegel & Walmsley LLC

+ HoldingHSIC

+3.94%

3M Return

G

Greenlight Capital, Inc.

+ HoldingHSIC

+3.43%

3M Return

Cronología de eventos

2026-08-04 (ET)

06:30:00

2026 EPS Consensus at $5.34, Revenue Growth View Raised to 4.5%-5.5%

06:30:00

Company Reports Q2 Revenue of $3.5B, Beating Expectations

2026-07-30 (ET)

07:30:00

Henry Schein Establishes Leadership Team, Restructures Executive Management

2026-06-30 (ET)

09:30:00

Henry Schein Partners with GoTu Technology for Dental Staffing Solutions

2026-05-22 (ET)

08:10:00

Henry Schein Appoints Daniel as Independent Chairman of the Board

Show More Events

Noticias

Show More News

HSIC FAQ — answered by Alphio AI

Henry Schein, Inc. is a solutions company for health care professionals. Its segments consist of Global Distribution and Value-Added Services, Global Specialty Products and Global Technology. Global Distribution and Value-Added Services include distribution to the global dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting and other practice services. This segment also markets and sells, under its own corporate brand, a portfolio of consumable merchandise. Global Specialty Products includes manufacturing, marketing and sales of dental implant and biomaterial products; endodontic, orthodontic and orthopedic products and other health care-related products and services. Global Technology includes development and distribution of practice management software, e-services, and other products. It operates in the Healthcare sector (WHOLESALE-MEDICAL, DENTAL & HOSPITAL EQUIPMENT & S industry).

Henry Schein Inc is a good buy right now due to its solid financial performance and positive market sentiment. The current price is $89.52, and the company reported a strong Q2 with a net income of $94 million and an EPS of $0.82, up from $0.70 last year. Additionally, the forward P/E ratio of 17.51 indicates attractive valuation relative to future earnings. However, the main risk is the debt to equity ratio, which is currently at 90.70%, indicating a high level of debt that could impact financial stability if not managed well.

16 analysts cover HSIC: 9 rate it Buy, 7 Hold and 0 Sell. The average price target is 76.78.

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empieza gratis